WHO ICTRP trial
Estudio Factorial de la Coadministracion de MK-0431 y Metformina en Pacientes…
PER-018-05 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-018-05 |
|---|---|
| Public title | Estudio Factorial de la Coadministracion de MK-0431 y Metformina en Pacientes con Diabetes Mellitus Tipo 2 |
| Scientific title | A FACTORIAL, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF THE CO-ADMINISTRATION OF MK-0431 AND METFORMIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2 WHO HAVE AN INAPPROPRIATE GLYCEMIC CONTROL |
| Primary sponsor | MERCK & CO.INC., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | III |
| Countries | Philippines;Malasya;Hungary;Lithuania;Norway;United Kindgdom;Russian Federation;Australia;New Zealand;Puerto Rico;South Africa;Colombia;Costa Rica;Guatemala;United States |
| Conditions | -E11 Non-insulin-dependent diabetes mellitus Non-insulin-dependent diabetes mellitus;E11 ;Non-insulin-dependent diabetes mellitus |
| Interventions | Group name:Group 1 Type of group;1 N° of participants:175 Intervention(s) description:1) Pharmacological Rest Period: 12 weeks. Suspension of any antihyperglycemic agent that the patient is taking 2) Transition Period: 2 weeks. All will… |
| Registration date | May 27, 2005 |
| Target size | 56 |
| Secondary IDs | NCT00103857 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: